Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD?

@inproceedings{Walton2016RepurposingTT,
  title={Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD?},
  author={Georgia M. Walton and James A. Stockley and Diane Griffiths and Charandeep S. Sadhra and Thomas L. Purvis and Elizabeth Sapey},
  booktitle={Journal of clinical medicine},
  year={2016}
}
Drug classes used in the treatment of Chronic Obstructive Pulmonary Disease (COPD) have not changed for many years, and none to date have shown disease-modifying activity. Statins are used to help reduce cardiovascular risk, which is high in many patients with COPD. Their use has been associated with improvements in some respiratory manifestations of disease and reduction in all-cause mortality, with greatest reductions seen in patients with the highest inflammatory burden. The mechanism for… CONTINUE READING
23
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

Frailty, sarcopenia and immunesenescence: shared mechanisms and clinical insights

VIEW 4 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Pulmonary Infections in the Elderly Lead to Impaired Neutrophil Targeting, Which Is Improved by Simvastatin.

  • American journal of respiratory and critical care medicine
  • 2017
VIEW 4 EXCERPTS
HIGHLY INFLUENCED

Lung Macrophage Phenotypes and Functional Responses: Role in the Pathogenesis of COPD

  • International journal of molecular sciences
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 108 REFERENCES